Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012:2012:472537.
doi: 10.1155/2012/472537. Epub 2012 Feb 23.

Viral bacterial artificial chromosomes: generation, mutagenesis, and removal of mini-F sequences

Affiliations
Review

Viral bacterial artificial chromosomes: generation, mutagenesis, and removal of mini-F sequences

B Karsten Tischer et al. J Biomed Biotechnol. 2012.

Abstract

Maintenance and manipulation of large DNA and RNA virus genomes had presented an obstacle for virological research. BAC vectors provided a solution to both problems as they can harbor large DNA sequences and can efficiently be modified using well-established mutagenesis techniques in Escherichia coli. Numerous DNA virus genomes of herpesvirus and pox virus were cloned into mini-F vectors. In addition, several reverse genetic systems for RNA viruses such as members of Coronaviridae and Flaviviridae could be established based on BAC constructs. Transfection into susceptible eukaryotic cells of virus DNA cloned as a BAC allows reconstitution of recombinant viruses. In this paper, we provide an overview on the strategies that can be used for the generation of virus BAC vectors and also on systems that are currently available for various virus species. Furthermore, we address common mutagenesis techniques that allow modification of BACs from single-nucleotide substitutions to deletion of viral genes or insertion of foreign sequences. Finally, we review the reconstitution of viruses from BAC vectors and the removal of the bacterial sequences from the virus genome during this process.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic illustration of shuttle mutagenesis. In a first step, a shuttle plasmid is inserted into the target sequence via RecA-mediated recombination of homologous sequences. Replication of the shuttle plasmid containing a temperature sensitive origin (oriTS) is repressed by a temperature increase to 42°C. Positive co-integrates are selected with corresponding antibiotics. In a second step, vector sequences are excised from co-integrates by another recombination. Negative selection markers can be used to select BAC constructs that lost the shuttle plasmid [28, 64]. Dotted lines symbolize recombination events.
Figure 2
Figure 2
Overview of strategies for the Red-mediated deletion of sequences. Boxes of same color represent identical sequences.
Figure 3
Figure 3
Overview of techniques that facilitate the insertion of a sequence of interest (soi) into a target site. Boxes of same color represent identical sequences.
Figure 4
Figure 4
Overview of strategies that allow sequence editing of the target sequences. Boxes of same color represent identical sequences.
Figure 5
Figure 5
Overview of strategies that allow mini-F removal upon virus reconstitution. Positive selection marker is portion of the BAC vector backbone. Boxes of same color represent identical sequences.

References

    1. Adachi S, Hori K, Hiraga S. Subcellular positioning of F plasmid mediated by dynamic localization of SopA and SopB. Journal of Molecular Biology. 2006;356(4):850–863. - PubMed
    1. Borst E, Messerle M. Development of a cytomegalovirus vector for somatic gene therapy. Bone Marrow Transplantation. 2000;25(supplement 2):S80–S82. - PubMed
    1. Neubauer A, Rudolph J, Brandmuller C, Just FT, Osterrieder N. The equine herpesvirus 1 UL34 gene product is involved in an early step in virus egress and can be efficiently replaced by a UL34-GFP fusion protein. Virology. 2002;300(2):189–204. - PubMed
    1. Rosas CT, König P, Beer M, Dubovi EJ, Tischer BK, Osterrieder N. Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins. Journal of General Virology. 2007;88(3):748–757. - PubMed
    1. Rosas CT, Tischer BK, Perkins GA, Wagner B, Goodman LB, Osterrieder N. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV) Virus Research. 2007;125(1):69–78. - PubMed

Publication types

LinkOut - more resources